ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026
Spinal cord syndrome: uncovering the risks of nitrous oxide abuse.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case report describes a 24-year-old male who developed subacute combined degeneration (SCD) as a result of chronic recreational nitrous oxide (N₂O) abuse over a six-month period. The patient presented with a two-week history of progressive paresthesias, initially affecting the feet and subsequently extending to the hips, along with lower limb numbness. Neurological examination revealed ataxia, hypoesthesia, impaired proprioception, and hyperreflexia, while muscle strength remained intact. Cerebrospinal fluid analysis showed mild protein elevation, and laboratory tests indicated macrocytic anemia with low vitamin B12 and elevated methylmalonic acid (MMA) levels. Homocysteine levels were within normal limits, likely due to the interval between the last use of N₂O and the blood test. MRI revealed T2-weighted hyperintensities in the spinal cord, consistent with SCD due to vitamin B12 deficiency. The patient had been using 100–200 canisters of N₂O daily but ceased use 10 days prior to hospitalization. After initiating vitamin B12 supplementation, he showed mild improvement. The patient underwent a three-month rehabilitation program, along with continued cyanocobalamin treatment, regaining the ability to walk independently. Follow-up MRI demonstrated a reduction in spinal cord lesions. This case highlights the increasing prevalence of nitrous oxide abuse; to date, this is the first documented case of SCD due to recreational N₂O use registered in Italy. Timely diagnosis and treatment, including vitamin B12 supplementation, are critical in preventing long-term neurological sequelae.
Indexed as
Identifiers
41766006What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.